Liver-specific therapies for metastases of neuroendocrine pancreatic tumors

被引：15
作者：
Fendrich, Volker [1 ]
Michl, Patrick [2 ]
Habbe, Nils [1 ]
Bartsch, Detlef Klaus [1 ]
机构：
[1] Philipps Univ, Dept Surg, D-35043 Marburg, Germany
[2] Philipps Univ, Dept Gastroenterol, D-35043 Marburg, Germany
来源：
WORLD JOURNAL OF HEPATOLOGY | 2010年 / 2卷 / 10期
关键词：
Liver metastasis; Neuroendocrine pancreatic tumor; Liver resection; Liver transplantation; Chemotherapy; Biotherapy;
D O I：
10.4254/wjh.v2.i10.367
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The presence or development of liver metastases in patients with neuroendocrine pancreatic tumors is the most important prognostic factor. Liver resection, transplantation and many different therapeutic approaches are discussed in this special review. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码：367 / 373
页数：7
相关论文
共 48 条
[1]   Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1 [J].
Bartsch, DK ;
Fendrich, V ;
Langer, P ;
Celik, I ;
Kann, PH ;
Rothmund, M .
ANNALS OF SURGERY, 2005, 242 (06) :757-766
[2]   Hepatic neuroendocrine metastases: Does intervention alter outcomes? [J].
Chamberlain, RS ;
Canes, D ;
Brown, KT ;
Saltz, L ;
Jarnagin, W ;
Fong, YM ;
Blumgart, LH .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 190 (04) :432-445
[3]   Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival? [J].
Chen, H ;
Hardacre, JM ;
Uzar, A ;
Cameron, JL ;
Choti, MA .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (01) :88-92
[4]  
DANFORTH DN, 1984, SURGERY, V96, P1027
[5]   Lethality of multiple endocrine neoplasia type I [J].
Doherty, GM ;
Olson, JA ;
Frisella, MM ;
Lairmore, TC ;
Wells, SA ;
Norton, JA .
WORLD JOURNAL OF SURGERY, 1998, 22 (06) :581-587
[6]   Metastatic endocrine tumors: Medical treatment, surgical resection, or liver transplantation [J].
Dousset, B ;
SaintMarc, O ;
Pitre, J ;
Soubrane, O ;
Houssin, D ;
Chapuis, Y .
WORLD JOURNAL OF SURGERY, 1996, 20 (07) :908-915
[7]  
EVANS DB, 1993, SURGERY, V114, P1175
[8]   Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors -: The International Lanreotide and Interferon Alfa Study Group [J].
Faiss, S ;
Pape, UF ;
Böhmig, M ;
Dörffel, Y ;
Mansmann, U ;
Golder, W ;
Riecken, EO ;
Wiedenmann, B .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2689-2696
[9]   An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors [J].
Fendrich, Volker ;
Langer, Peter ;
Celik, Ilhan ;
Bartsch, Detlef K. ;
Zielke, Andreas ;
Ramaswamy, Anette ;
Rothmund, Matthias .
ANNALS OF SURGERY, 2006, 244 (06) :845-853
[10]   Surgical management of pancreatic endocrine tumors [J].
Fendrich, Volker ;
Waldmann, Jens ;
Bartsch, Detlef K. ;
Langer, Peter .
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (07) :419-428
12345